Startup Phantom Neuro is pioneering the future of prosthetics with its innovative wristband-like device designed to be implanted under the skin, allowing users to control prosthetic limbs by reading nerve impulses. Recently, the company secured $19 million in funding, marking a significant step towards commercialization enabled by two FDA designations. Its breakthrough technology, built on the phantom limb phenomenon, demonstrated 94% accuracy in nerve impulse translation for prosthetic movements during a clinical study. With leading support from Ottobock and other prominent investors, Phantom Neuro has raised a total of $28 million, setting the stage for enhanced functionality in amputees.
Phantom Neuro, a startup developing implanted wristband devices for controlling prosthetics, has raised $19 million and aims to revolutionize prosthetic technology.
With FDA approval as a Breakthrough Device, Phantom Neuro's technology, based on phantom limb phenomena, shows significant promise in restoring functionality for amputees.
The Phantom X software demonstrated 94% accuracy in translating nerve impulses to prosthetic movements, highlighting impressive calibration efficiency and user functionality restoration.
Led by Ottobock, the funding brings Phantom Neuro's total to $28 million, indicating strong investor confidence in the startup's revolutionary approach to prosthetic control.
Collection
[
|
...
]